Current/ Expected Orderbook/ Pending Orders?

The discussion on the order book specifically highlights that the new products are contributing approximately 70% to the order book on an annualized average basis. For example, Quarter 1 bookings for Ronfen are around Rs. 70 crores, and Quarter 2 is expected to be higher due to seasonality. CTPR contributes roughly Rs. 20 crores in bookings. The total revenue posted is around Rs. 600 crores, with major contributions from products like Ronfen, CTPR, AXEMAN, Warden, Tombo, Amito, and Propique. The company emphasizes that most bookings and revenue growth are driven by these new and specialized pr

Any current/future new fundraising through debt or equity?

Currently, Best Agrolife Limited is managing its CAPEX and operational funding through internal accruals, supported by healthy EBITDA margins and efficient working capital management. As stated by Sanjeev Kharbanda, so far, the company has been able to fund growth and CAPEX through internal sources without the need for debt. However, as the company approaches Greenfield project expansions aligned with its revenue growth targets, it anticipates exploring additional funding options. This implies that in the near future, Best Agrolife may consider raising debt or equity to support larger scale

Any current/future capex/capital investment/strategic investment?

Best Agrolife has planned an overall CAPEX of around Rs. 200 crores primarily for: - Capacity enhancement - Backward integration to support market demand - Investment in R&D and market footprint expansion Actual cash outflow for CAPEX for the current financial year is expected to be around Rs. 100-150 crores, with some spillover to next year. A separate registration budget of around Rs. 50 crores is allocated for export development, product registration, and market studies. The company is exploring green energy initiatives, having signed a 3 MW solar power purchase agreement to reduce en

Future growth expectations in sales/revenue/volumes?

Best Agrolife targets approximately 30% revenue growth for FY24, building on Q1's robust 32% YoY growth. Q2 and Q3 are expected to be stronger quarters due to seasonal demand, especially for products like Ronfen. New product launches contribute around 70% of annualized revenue, expected to drive further growth. The company aims to maintain a 20% EBITDA margin alongside the revenue growth. Sales projections include Ronfen reaching Rs. 350-400 crores for the full year, with significant contributions from CTPR and other key products like Warden, Bestie, Bestline, and Pymax. Investment i

Best AgrolifeQ1 FY24Fertilizers & Agrochemicals

Best Agrolife Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹17.5P/E: 21.9Market Cap: ₹647 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

Best Agrolife targets approximately 30% revenue growth for FY24, building on Q1's robust 32% YoY growth.
Q2 and Q3 are expected to be stronger quarters due to seasonal demand, especially for products like Ronfen.
New product launches contribute around 70% of annualized revenue, expected to drive further growth.
The company aims to maintain a 20% EBITDA margin alongside the revenue growth.
Sales projections include Ronfen reaching Rs. 350-400 crores for the full year, with significant contributions from CTPR and other key products like Warden, Bestie, Bestline, and Pymax.
Investment in capacity enhancement and backward integration with Rs. 200 crores CAPEX will support volume growth.
Export strategy planned for FY25 aims to tap into international markets, adding to future growth.
Overall, Best Agrolife is confident of sustaining growth through specialized patented products and expanding market presence.

Margin guidance

Category 3

- The company targets approximately 30% top-line growth over the previous year, maintaining robust revenue momentum. - EBITDA margin guidance is to sustain around 20%, reflecting a focus on profitability amid market challenges. - Management expects continued improvement in revenue driven by specialized, patented, and branded products, with newer launches contributing significantly in Q2 and Q3. - CAPEX of Rs. 200 crores is planned for capacity expansion and backward integration, supporting growth. - The company is optimistic about crossing Rs. 1,000 crore revenue in the near term fueled by product launches like Ronfen and CTPR. - Profit After Tax (PAT) showed a 124% YoY increase in Q1 FY24; growth is expected to continue with a focus on margins and operational efficiency. - Export plans from FY25 onward are expected to add incremental growth opportunities. Overall, Best Agrolife aims for sustained double-digit growth in earnings supported by innovative product mix and efficient cost management.

See what Best Agrolife management said on margin guidance — free account, 30 seconds.

Fundraise plans

Currently, Best Agrolife Limited is managing its CAPEX and operational funding through internal accruals, supported by healthy EBITDA margins and efficient working capital management.
As stated by Sanjeev Kharbanda, so far, the company has been able to fund growth and CAPEX through internal sources without the need for debt.
However, as the company approaches Greenfield project expansions aligned with its revenue growth targets, it anticipates exploring additional funding options.
This implies that in the near future, Best Agrolife may consider raising debt or equity to support larger scale expansions but no concrete plans or timelines were disclosed during the call.

Order book

Yes

The discussion on the order book specifically highlights that the new products are contributing approximately 70% to the order book on an annualized average basis.
For example, Quarter 1 bookings for Ronfen are around Rs. 70 crores, and Quarter 2 is expected to be higher due to seasonality.
CTPR contributes roughly Rs. 20 crores in bookings.
The total revenue posted is around Rs. 600 crores, with major contributions from products like Ronfen, CTPR, AXEMAN, Warden, Tombo, Amito, and Propique.
The company emphasizes that most bookings and revenue growth are driven by these new and specialized products within their portfolio.
Overall, the order book reflects strong demand especially from new patented and specialized formulations.

See what Best Agrolife management said on order book — free account, 30 seconds.

Capex plans

Yes

Best Agrolife has planned an overall CAPEX of around Rs. 200 crores primarily for:
- Capacity enhancement
- Backward integration to support market demand
- Investment in R&D and market footprint expansion
Actual cash outflow for CAPEX for the current financial year is expected to be around Rs. 100-150 crores, with some spillover to next year.
A separate registration budget of around Rs. 50 crores is allocated for export development, product registration, and market studies.
The company is exploring green energy initiatives, having signed a 3 MW solar power purchase agreement to reduce energy costs by 33% and lower carbon footprint (~4,000 tonnes annually).
Future funding for expansion may require additional debt once the company scales up to Greenfield projects, though currently CAPEX is funded through internal accruals.

Track Best Agrolife — get its next earnings analysis in your feed

How does Best Agrolife rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisBest Agrolife

Rev 2Mar 3

See where Best Agrolife sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Best Agrolife rank in Fertilizers & Agrochemicals?

Compare Best Agrolife against every Fertilizers & Agrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Best Agrolife's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
Bhagiradha Chemicals & Industries Ltd (Q4 FY26)
158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Bhagiradha Chemicals & Industries Ltd (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →